Tango Therapeutics TNGX Pre-Tax Income
Discontinued — last reported Q1 '26
Pre-Tax Income at other companies
Other financials
Where this comes from
Reported directly by Tango Therapeutics in its filing.
Tagged under the XBRL concept us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest.
The official record: Tango Therapeutics’s 10-Q, filed May 13, 2026, on SEC EDGAR. View the filing →
Ask your AI about Tango Therapeutics's pre-tax income.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Tango Therapeutics's pre-tax income?
- Tango Therapeutics (TNGX) reported pre-tax income of -$45.51M in Q1 2026.
- How has Tango Therapeutics's pre-tax income changed year-over-year?
- Tango Therapeutics's pre-tax income decreased by 14.2% year-over-year, from -$39.84M to -$45.51M.
- What is the long-term trend for Tango Therapeutics's pre-tax income?
- Over 4 years (2021 to 2025), Tango Therapeutics's pre-tax income has grown at a 15.1% compound annual growth rate (CAGR), from -$57.94M to -$101.59M.
- What does pre-tax income mean?
- Total income from all sources — operating income plus non-operating items like interest income, investment gains, and other income — before the provision for income taxes.